Schellhammer Urological Research Foundation
Today's Research Offers Tomorrow's Hope
Home
Welcome Clinicians
About Us
Newsletters
Events
Patient Information
Links
Publications
About Us
Annual Report

 

1.                  The Clinical Trials Division revenue is received from grants from pharmaceutical and device companies to support investigative research studying new pharmaceutical agents and new instrumentation.  These grants are negotiated prior to the trial by presentation of a detailed budget which allows coverage of trial expenses; specifically support of personnel for monitoring patient progress and providing detailed documentation that adheres to good practice principles, institutional review board requirements and FDA requirements.

 

 

CLINICAL TRIALS DIVISION

 

2007

2008

Operating Income

309, 118

297,097

Investment gain/loss

25,249

6,386

Operating Expenses & Contributions to Basic Research

268,891

318,108

TOTAL

65,476

(14,625)

 

 

2.                  The Basic Science Division derives its revenue from philanthropic support and governmental grant support.  Governmental grants typically extend from 3-5 years and are not included in the annual Basic Research support.  Expenses in the Basic Research Division include personnel, and significantly for IT and hardware support.  Increasingly the cost of necessary instrumentation has risen and consumed a good portion of the Basic Research resources as evidenced by the 2007-2008 annual report of revenue and expenses. 

 

 

BASIC SCIENCE DIVISION

 

2007

2008

BEGINNING BALANCE

226,410.60

263,248.73

REVENUES

   Donations

   Contributions from Clinical Research

                       TOTAL

 

219,432.69

16,953.58

236,386.27

 

175,595.02

28,933.01

204,528.03

EXPENSES

   Salary and Fringe Benefits

   Postage

   IT Hardware / software

   Travel / meetings / journals

   Printing costs

   Other – General expenses                              

   Accrued equipment purchase

   Misc

                       TOTAL

 

95,058.00

1,282.48

4,750.00

3,531.80

3,586.02

1,477.62

88,220.00

1,642.08

199,548.14

 

95,695.00

1,200.00

1,312.40

8,404.02

5,467.68

3,023.98

297,486.00

 

409,565.10

ENDING BALANCE

263,248.73

58,211.66